Brief: Prostatype Genomics Enters Into Top-Down Underwriting
09/07/2026 06:51
BRIEF-Prostatype Genomics Enters Into Top-Down Underwriting July 9 (Reuters) - Prostatype Genomics AB PROGEN.ST:
SAID ON WEDNESDAY CO ENTERED INTO TOP-DOWN UNDERWRITING AHEAD OF UPCOMING RIGHTS ISSUE OF UNITS
TOP-DOWN UNDERWRITING OF ABOUT 10.1 MSEK, CORRESPONDING TO ABOUT 21.3% OF THE ISSUE PROCEEDS
RIGHTS ISSUE THUS COVERED BY SUBSCRIPTION COMMITMENTS, BOTTOM- AND TOP-DOWN UNDERWRITING UNDERTAKINGS TOTALLING ABOUT 43.2 MSEK, CORRESPONDING TO ABOUT 91.3% OF MAXIMUM ISSUE PROCEEDS
Source text for Workspace: nMFN88z4YV
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue